Article Text
Abstract
Given the dramatic shortage of transplantable organs, demand cannot be met by established and envisioned organ procurement policies targeting postmortem donation. Live organ donation (LOD) is a medically attractive option, and ethically permissible if informed consent is given and donor beneficence balances recipient non-maleficence. Only a few legal and regulatory frameworks incentivise LOD, with the key exception of Israel’s Organ Transplant Law, which has produced significant improvements in organ donation rates. Therefore, I propose an organ procurement system that incentivises LOD by allocating additional priority points to the living donor on any transplant waiting list. I outline benefits and challenges for potential recipients, donors and society at large, and suggest measures to ensure medical protection of marginalised patient groups.
- allocation of organs/tissues
- transplantation
Data availability statement
There are no data in this work.
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Who is willing to take the risk? Assessing the readiness for living liver donation in the general German population
- Developing an ethics framework for living donor transplantation
- Self-interest, self-abnegation and self-esteem: towards a new moral economy of non-directed kidney donation
- May I have your uterus? The contribution of considering complexities preceding live uterus transplantation
- Postmortem non-directed sperm donation: quality matters
- Limits to liver transplantation in the UK
- Opting out: confidentiality and availability of an ‘alibi’ for potential living kidney donors in the USA
- The potential for neonatal organ donation in a children's hospital
- Should gratitude be a requirement for access to live organ donation?
- Live kidney donation from a person with haemophilia